US

Byeong Doo Song

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Byeong Doo Song. Retrieved from https://idiyas.com/inventor/byeong-doo-song-hn2mxqqd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Byeong Doo Song: Innovator in Antibody Library Technologies

Introduction

Byeong Doo Song is a notable inventor based in the United States. He has made significant contributions to the field of biotechnology, particularly in the development of combinatorial antibody libraries. His work focuses on methods for creating these libraries from human germline segments, which are crucial for advancing therapeutic antibody development.

Latest Patents

Byeong Doo Song holds a patent titled "Combinatorial Antibody Libraries And Uses Thereof." This patent outlines methods for constructing a combinatorial antibody library from human germline segments. It also details libraries of nucleic acid molecules compiled from germline segments encoding VL chains and VH chains, resulting in valuable antibody libraries. The libraries are designed to be addressable, allowing for efficient screening against target protein antigens.

Career Highlights

Byeong Doo Song is currently associated with Taurus Biosciences, LLC, where he continues to innovate in the field of antibody technology. His expertise in combinatorial libraries has positioned him as a key player in the biotechnology sector.

Collaborations

He has collaborated with notable colleagues such as Vaughn Smider and James Graziano, contributing to advancements in antibody research and development.

Conclusion

Byeong Doo Song's work in combinatorial antibody libraries represents a significant advancement in biotechnology. His innovative methods and collaborations continue to influence the field, paving the way for future developments in therapeutic antibodies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…